Blood flow measurement devices are used to diagnose various vascular diseases by determining blood circulation levels. These devices measure blood flow non-invasively with technologies like Doppler ultrasound, laser Doppler flowmetry, and electromagnetic flowmetry. They are utilized across healthcare sectors like cardiology, vascular surgery, and critical care units to screen for peripheral artery disease, deep vein thrombosis, and assess vasodilatory responses. Blood flow measurement finds widespread application in diagnosing and managing conditions affecting blood vessels and circulation like atherosclerosis, diabetes-related macro- and microvascular complications. Given the increasing prevalence of cardiovascular disorders worldwide, demand for accurate and continuous blood flow monitoring is on the rise.

The Global Blood Flow Measurement Devices Market is estimated to be valued at US$ 639.5 million in 2024 and is expected to exhibit a CAGR of 8.8% over the forecast period 2023 to 2030.

Key Takeaways

Key players operating in the blood flow measurement devices are Arjo, Atys Medical, Compumedics Ltd., Cook Medical Inc., Deltex Medical Ltd., GF Health Products, Inc., Medistim ASA, Moor Instruments Ltd., Perimed AB, Transonic Systems, Inc., Medtronics, Biomedix Inc, AKW Medicals Inc., D E Hokanson Inc., Elcat GmBH, Flowtronics Inc., Ace Medicals, Carolina Medical Plc, and Compumedics Ltd. Rising incidence of vascular diseases is a major factor propelling demand for these monitoring systems. Technological advancements have led to the development of non-invasive and continuous blood flow assessment techniques.

Market Trends

Two major trends can be witnessed in the blood flow measurement devices market. Home healthcare is gaining prominence with the development of portable and easy-to-use blood flow monitors. This enables continuous remote monitoring and earlier disease diagnosis. AI and IoT integration is also improving the capabilities of these devices. Machine learning algorithms can now detect anomalies and warn care teams proactively. Data collected from multiple patients can provide automated insights to physicians for treatment modifications.

Market Opportunities

Growing geriatric population susceptible to circulatory issues will boost market revenues. According to estimates, over 16% of the global population will be aged over 65 by 2050. This widens the target base for blood flow monitoring solutions. Another key opportunity lies in increasing access to devices in emerging markets. With better awareness and availability, more patients can benefit from these diagnostic aids.

Impact of COVID-19 on the Blood Flow Measurement Devices Market
The COVID-19 pandemic has significantly impacted the growth of the blood flow measurement devices market. During the peak of the pandemic in 2020-2021, hospitals capacities were overwhelmed treating COVID patients which led to the postponement of non-essential surgeries and procedures. This impacted the demand for blood flow measurement devices in the short term. However, as the pandemic progressed, more focus was given to treating chronic diseases as well. This led to a gradual recovery of the market towards the latter half of 2021.

Going forward, as the pandemic situation eases with more people getting vaccinated, the demand for blood flow measurement devices is expected to regain momentum. However, supply chain disruptions caused due to lockdowns will continue to pose challenges in the near future. Medical device manufacturers will need to closely monitor inventory levels and diversify supplier bases to mitigate future disruptions. Telehealth is also expected to play a bigger role in monitoring chronic disease patients remotely to minimize physical visits to hospitals and reduce infection risk. This will drive innovative wireless and remote monitoring blood flow measurement technologies.

The United States accounts for the largest share of the global blood flow measurement devices market in terms of value. This is attributed to the rising prevalence of cardiovascular diseases, growing geriatric population suffering from mobility issues and strong healthcare infrastructure. However, the market experienced short term decline during the peak of pandemic owing to canceled elective surgeries. The region is expected to regain momentum in coming years backed by rising healthcare spending.

The Asia Pacific region represents the fastest growing market for blood flow measurement devices globally. This growth can be attributed to increasing healthcare expenditure, large patient pools suffering from chronic diseases, growing medical tourism industry and prevalence of lifestyle diseases. Countries like China, India and Japan are expected to be major revenue generators. However, the market experienced temporary setbacks during the initial phase of pandemic due to lockdowns and supply chain disruptions across the region. It is anticipated to pick up pace again with resumption of healthcare services and economic activities.